These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps. Azamat S, Karaman Ş, Azamat IF, Ertaş G, Kulle CB, Keskin M, Sakin RND, Bakır B, Oral EN, Kartal MG. Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976 [Abstract] [Full Text] [Related]
28. Value of percent change in tumoral volume measured at T2 -weighted and diffusion-weighted MRI to identify responders after neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma. Quaia E, Gennari AG, Ricciardi MC, Ulcigrai V, Angileri R, Cova MA. J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471 [Abstract] [Full Text] [Related]
29. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy? Yu SK, Tait D, Chau I, Brown G. Int J Radiat Oncol Biol Phys; 2013 Nov 01; 87(3):505-11. PubMed ID: 24074924 [Abstract] [Full Text] [Related]
30. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging. Blazic IM, Lilic GB, Gajic MM. Radiology; 2017 Feb 01; 282(2):418-428. PubMed ID: 27253423 [Abstract] [Full Text] [Related]
35. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Yu J, Xu Q, Song JC, Li Y, Dai X, Huang DY, Zhang L, Li Y, Shi HB. Eur Radiol; 2017 May 01; 27(5):1848-1857. PubMed ID: 27631106 [Abstract] [Full Text] [Related]
36. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation. Kim NK, Baik SH, Min BS, Pyo HR, Choi YJ, Kim H, Seong J, Keum KC, Rha SY, Chung HC. Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):204-10. PubMed ID: 17084555 [Abstract] [Full Text] [Related]
37. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Yang L, Xia C, Liu D, Fang X, Pan X, Ma L, Wu B. Acta Radiol; 2020 Sep 01; 61(9):1155-1164. PubMed ID: 31924105 [Abstract] [Full Text] [Related]
38. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer. Kim S, Han K, Seo N, Kim HJ, Kim MJ, Koom WS, Ahn JB, Lim JS. Eur Radiol; 2018 Dec 01; 28(12):5231-5240. PubMed ID: 29858637 [Abstract] [Full Text] [Related]
39. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters. Fusco R, Sansone M, Granata V, Grimm R, Pace U, Delrio P, Tatangelo F, Botti G, Avallone A, Pecori B, Petrillo A. Abdom Radiol (NY); 2019 Nov 01; 44(11):3683-3700. PubMed ID: 30361867 [Abstract] [Full Text] [Related]
40. Diffusion-weighted imaging for evaluating lymph node eradication after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. Ryu KH, Kim SH, Yoon JH, Lee Y, Paik JH, Lim YJ, Lee KH. Acta Radiol; 2016 Feb 01; 57(2):133-41. PubMed ID: 25638800 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]